CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
350 employees · est. 2013 · Boston, United States
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
7 employees · est. 2016 · San Diego, United States
CRISPR Therapeutics is the older company (2013 vs 2016); CRISPR Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | CRISPR Therapeutics | Locanabio, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2016 |
| Headquarters | ||
| Headquarters | Boston, United States | San Diego, United States |
| Employees | ||
| Employees | 350 larger | 7 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Series B |
| Total Funding | ||
| Total Funding | $1.05B | $155.55M |
| Funding Rounds | ||
| Funding Rounds | 7 | 3 |
| Services | ||
| Services | Development of gene-based medicines, Gene-editing therapies, Clinical and preclinical research, Patient advocacy | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with serious diseases, Healthcare providers, Biotechnology companies, Research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Gene-based Medicines, CRISPR Technology, Gene Editing, Hematology, Oncology, Regenerative Medicine, Cardiovascular Diseases, Autoimmune Diseases, Rare Diseases, Transfusion-Dependent Beta Thalassemia, Sickle Cell Disease, Biopharmaceuticals, CRISPR/Cas9 Platform, Strategic Partnerships, Nobel Prize-winning Innovations | RNA-targeting Gene Therapy, Genetic Medicine, Neurodegenerative Diseases, Neuromuscular Diseases, Rare Genetic Diseases, RNA Biology, Gene Editing, Genomic Medicine, RNA-mediated Disease, Drug Development, Neurological Disorders |
| Website | ||
| Website | crisprtx.com | locanabio.com |
About CRISPR Therapeutics
CRISPR Therapeutics, a leader in biopharma and biotechnology, stands at the forefront of creating gene-based medicines for patients with serious diseases. Since its founding in 2013, the company has not only evolved but thrived by leveraging CRISPR technology, a Nobel Prize-winning innovation that h...
About Locanabio, Inc.
Locanabio, Inc., founded in 2016, is at the forefront of developing RNA-targeting gene therapies to address significant unmet medical needs. Their innovative approach focuses on correcting disease-causing RNA, utilizing a proprietary platform that includes advanced systems like snRNA, Cas13d, and PU...
We will tell you when either one moves
BounceWatch watches CRISPR Therapeutics and Locanabio, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at CRISPR Therapeutics and Locanabio, Inc. — by email.
Frequently Asked Questions
Compare CRISPR Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at CRISPR Therapeutics on 3 Jul 2026, and Locanabio, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
